Biopharma

New era of affordable insulin

Disease management for chronic conditions can be tricky if the cost of medications is unaffordable. Patients, especially the Medicare population, tend to ration the drugs in order to avoid high costs as these require prolonged usage. According to CVS Health, more than 30 million Americans are living with diabetes, one-third of whom do not have […]

Acute respiratory distress syndrome doubles in U.S. during COVID-19

Acute respiratory distress syndrome (ARDS), one of the most severe consequences of COVID-19, is often fatal and may develop in COVID-19 patients already in a critically ill state. To examine the impact of the COVID-19 pandemic on ARDS risk, we analysed the number of patients in the United States making medical claims for ARDS between […]

Role of advanced IDNs grows as COVID-19 shifts market dynamics

The COVID-19 pandemic is fundamentally changing healthcare delivery in the United States, from the acceptance of virtual physician visits to payment reform, and from the consolidation of integrated delivery networks to the very survival of independent physician practices. The resultant healthcare environment will be one that is more integrated into daily life with provider reimbursement […]

Physician practice ownership set for radical change as COVID-19 strains finances

The COVID-19 pandemic is fundamentally changing healthcare delivery in the United States, from the acceptance of virtual physician visits to payment reform, and from the consolidation of integrated delivery networks to the very survival of independent physician practices. Clarivate market access expert Heather Johnson discusses how physician practice ownership is expected to evolve due to the pandemic. […]

Telehealth here to stay as unprecedented times drive innovation

The COVID-19 pandemic is fundamentally changing healthcare delivery in the United States. Clarivate market access expert Valerie Pillo discusses where the telehealth market is heading post-pandemic.   Telehealth has played a critical role in healthcare delivery during the COVID-19 pandemic, advancing its capabilities years ahead of its expected trajectory. It will likely become an integral part of […]

Hospital infections dip during pandemic

  Effect on COVID-19 and lockdown measures in the United States on hospital-acquired or hospital-treated infection shows stark contrast compared to the same period in 2019   Our analysis U.S. claims data shows that the number of admissions with hospital-acquired or hospital-treated infections between April-May 2019 and the same period in 2020 have dropped sharply […]

Key ESMO Highlights 2020

As a result of the current COVID-19 pandemic, the annual ESMO Congress was held virtually between 19th and 21st September 2020. Over 2,100 oral presentations and posters were presented, showcasing exciting novel data across oncology, with the ultimate aim of improving cancer patient care. Here DRG/Clarivate highlights the most impactful presentations on drug treatment landscapes. […]

GSK’s first-in-class anti-BCMA therapy wins regulatory approval

GSK’s BLENREP has become the first anti-BCMA therapy to secure a position in the treatment algorithm of multiple myeloma (relapsed or refractory setting). This approval was a highly anticipated event and significant for the multiple myeloma treatment landscape because it helps address an important unmet need for patients who have received at least four prior […]

Resilient supply chain requires geographic diversity

Manufacturing location is vital to securing the biopharma supply chain – for the finished product, APIs and the raw materials. How vulnerable are we?   “There’s a difference in knowing something and realizing something. We’ve known for quite a while now that we’re too dependent on other countries for our medical supplies. But during this […]